Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 December 2019 Photo Shaari Rai Poken
Kweku
From Bloemfontein to Bremen: Kweku Gavor represented South Africa well in Germany.

It all started with the Umoja Buddy Programme (UBP). Kweku Gavor was a UBP ambassador when he met exchange students from Germany. Two years later, the roles were reversed. “Helping out students who later have become my really good friends opened up the opportunity for me to study abroad in Germany.” he said.

Kweku spent about four months as part of a pilot Summer Lab Programme at Universität Bremen after being nominated for a scholarship by the German Academic Exchange Service, which his former Umoja buddies helped create. He shared the experience with eight other students from Palestine, Poland, Ukraine, and the US. The focus was on Business Studies, Marketing and Economics.

According to the BCom graduate, studying internationally gave him new insights. “The experience opened my mind and better-equipped me to work in situations in which I need to handle a lot of pressure against the clock.”

The first leg of the programme featured corresponding modules presented in a classroom environment, which were integrated with assignments, presentations, tests and exams. This was supplemented by a language course that involved cultural leadership training. Another crucial part of the Summer Lab Programme was an internship where students were placed with companies and tasked with a problem-solving project. Kweku was placed at Fabular Ai, an artificial intelligence company which designs computer software.

“Going to study abroad is an extremely rare and fantastic opportunity I advise all who can to grab it with both hands,” said Kweku, who also used the opportunity to travel all over Europe.

Internationalisation at home with Umoja

The UBP, which is collaboratively run by the UFS Office for International Affairs and Student Affairs, played a big part in Kweku being given the opportunity to study abroad. However, unlike him, not all students have to the opportunity to engage in undergraduate exchanges.

The UBP is part of the university’s efforts to advance internationalisation at home, as anchored in the UFS Strategic Plan: 2018-2022. With the programme, students are able to receive an international experience on home ground.

The programme aims to connect international and local students through meaningful lifelong friendships and foster their academic, social and cultural integration. It pairs first-entry international students with senior Kovsies who provide a warm, welcoming, friendly face, and a helping hand.

Expression of interest sought

A total of 48 ambassadors were enrolled in 2019. To join the UBP in 2020, contact Sonya Kapfumvuti at KapfumvutiSCR@ufs.ac.za or call her on 051 401 3397.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept